TEMPE, Ariz., Feb. 13 /PRNewswire-FirstCall/ - Nutraceutical company, Health Enhancement Products, Inc. (OTC: HEPI) today announced that results from recent independent blood tests on eight patients suggest that ProAlgaZyme may support a compromised immune system. All eight patients were administered Health Enhancement Products' ProAlgaZyme daily beginning in October 2003 and while under the supervision of their attending physicians. Significant improvements were realized within the first month including increased energy levels, weight gain, and alertness.

DeWall J. Hildreth, D.O., Health Enhancement Product's Director of Medical Research, said, "ProAlgaZyme's results to date are extremely encouraging. Internal research studies over the past three years have consistently shown that ProAlgaZyme supports a compromised immune system. Patients have experienced improvements in their immune system with no side effects due to ProAlgaZyme's 100% pure nature."

Howard Baer, Chief Executive Officer of Health Enhancement Products, Inc., said, "This study follows the positive results recently published by Arizona State University on ProAlgaZyme. We continue to work with independent research organizations as awareness of ProAlgaZyme becomes more widespread. We have also been approached by numerous physicians and potential strategic partners seeking to explore potential applications and alliances with our company. We have very high expectations for ProAlgaZyme due to its enormous potential in terms of possible uses and generating revenue."

About Health Enhancement Products, Inc.
Health Enhancement Products, Inc. (OTC: HEPI) is a nutraceutical company directed specifically at the development and marketing of supplementary health-enhancing products using only pure, all-natural and herbal extracts. In particular, Health Enhancement's products use beneficial herbal extracts, vitamins, minerals, and botanical extracts in varying combinations to address common or specific illnesses.

The Company's sole product is ProAlgaZyme that is produced from an algae grown in 100% distilled water. The algae produces an enzyme as a means of protecting itself from exposure to outside disease and harmful bacteria. The enzyme is then drawn off, filtered, tested and bottled for consumption. Recent clinical trials performed by the Company have indicated that ProAlgaZyme may increase and activate the white blood cells in individuals whose white cells are low or inactive, in effect enhancing the immune system. Heath Enhancements is currently doing internal clinical trials on several illnesses and diseases with ProAlgaZyme, including various types of cancer, HIV/AIDS, diabetes and Chronic Fatigue Syndrome.

ReplenTish is currently available for sale exclusively on
our websites www.heponline.com or www.replentish.com .


CONTACTS:
Health Enhancement Products, Inc.
480-385-3800

This press release may contain forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.